Key Insights

Highlights

Success Rate

73% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

20.0%

3 terminated out of 15 trials

Success Rate

72.7%

-13.8% vs benchmark

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed with results

Key Signals

4 with results73% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (8)
P 1 (1)
P 2 (2)
P 3 (1)
P 4 (1)

Trial Status

Completed8
Unknown3
Terminated3
Recruiting1

Trial Success Rate

72.7%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (15)

Research Network

Activity Timeline